Effect of selenium on cisplatin-induced nephrotoxicity in rats

Nephron - Experimental Nephrology

Volumn 104, Issue 3, 2006, Pages

  Fujieda, Mikiya ^a   Naruse, Keishi ^b   Hamauzu, Tadashi ^a   Miyazaki, Eriko ^a   Hayashi, Yoshihiro ^a   Enomoto, Riyo ^c   Lee, Eibai ^c   Ohta, Kazuhide ^d   Wakiguchi, Hiroshi ^a   Enzan, Hideaki ^a  

^a KOCHI UNIVERSITY   (Japan)

^b National Hospital Organization Kochi National Hospital   (Japan)

^c KOBE GAKUIN UNIVERSITY   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cisplatin; Glutathione peroxidase; Nephrotoxicity; Selenium

Indexed keywords

4 HYDROXYNONENAL; CISPLATIN; GLUTATHIONE PEROXIDASE; HEME OXYGENASE 1; MESSENGER RNA; SELENIUM; SODIUM SELENITE; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY TUBULE DAMAGE; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SELENIUM DEFICIENCY; STATISTICAL ANALYSIS; URINALYSIS;

ADMINISTRATION, ORAL; ALDEHYDES; ANIMALS; ANTIOXIDANTS; CISPLATIN; CYTOPROTECTION; GLUTATHIONE PEROXIDASE; HEME OXYGENASE-1; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASES; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; SELENIUM; VIMENTIN;

EID: 33750064307     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094550     Document Type: Article

References (34)

1. Lebwohl D, Canetta R: Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 1998;34:1522-1534.
2. Blachley JD, Hill JB: Renal and electrolyte disturbances associated with cisplatin. Ann Intern Med 1981;95:628-632.
3. Masuda H, Tanaka T, Takahama U: Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 1994;203:1175-1180.
4. Kruidering M, Van de Water B, de Heer E, Mulder GJ, Nagelkerke JF: Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J Pharmacol Exp Ther 1997;280:638-649.
5. Matsushima H, Yonemura K, Ohishi K, Hishida A: The role of oxygen free radical in cisplatin-induced acute renal failure in rats. J Lab Clin Med 1998;131:518-526.
6. Zhang JG, Lindup WE: Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slices. Biochem Pharmacol 1993;45:2215-2222.
7. Hu Y, Chen Y, Zhang Y, Zhou M, Song X, Zhang B, Luo L, Xu P, Zhao Y, Cheng G: The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients. Biol Trace Elem Res 1997;56:331-341.
8. Francescato HDC, Costa RS, Camargo SMR, Zanetti MA, Lavrador MA, Bianchi MLP: Effect of oral selenium administration on cisplatin-induced nephrotoxicity in rats. Pharmacol Res 2001;43:77-82.
9. Satoh M, Kashihara N, Fujimoto S, Horike H, Tokura T, Namikoshi T, Sasaki T, Makino H:A novel free radical scavenger, edarabon, protects against cisplatin-induced acute renal damage in vitro and in vivo. J Pharmacol Exp Ther 2003;305:1183-1190.
10. Alfthan G, Kumpulainen J: Determination of selenium in small volumes of blood plasma and serum by electrothermal atomic absorption spectrometry. Ann Chim Acta 1982;140:221-227.
11. Morimmoto K, Ohta K, Yachie A, Yang Y, Shimizu M, Goto C, Toma T, Kasahara Y, Yokoyama H, Miyata T, Seki H, Koizumi S: Cytoprotective role of heme oxygenase (HO)-1 in human kidney with various renal diseases. Kidney Int 2001;60:1858-1866.
12. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
13. Paglia DP, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-169.
14. L'Abbe MR, Trick KD: Changes in pancreatic glutathione peroxidase and superoxide dimutase activities in the prediabetic diabetes-prone BB rat. Proc Soc Exp Biol Med 1994;207:206-212.
15. Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AM: CTGF expression is induced by TGF-β in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 2000;32:1805-1819.
16. Dauggard G, Holstein-Rathlou NH, Leyssac PP: Effect of cisplatin on proximal convoluted and straight segments of the rat kidney. J Pharmacol Exp Ther 1988;244:1081-1085.
17. Rao M, Kuman MM, Rao MA: In vitro and in vivo effects of phenolic antioxidants against cisplatin-induced nephrotoxicity. J Biochem 1999;125:383-390.
18. Saad SY, Najjar TA, Noreddin AM, Al RA: Effects of gemcitabine on cisplatin-induced nephrotoxicity in rats: schedule-dependent study. Pharmacol Res 2001;43:193-198.
19. Goldstein RS, Mayor GH: The nephrotoxicity of cisplatin. Life Sci 1983;32:685-690.
20. Choie DD, Longnecker DS, Del Campo AA: Acute and chronic cisplatin nephropathy in rats. Lab Invest 1981;44:397-402.
21. Tolstrong GV, Shoerman RC, Traub U, Traub P: Role of intermediate filament protein vimentin is delaying senescence and in the spontaneous immortalization of mouse embryo fibroblasts. DNA Cell Biol 2001;20:509-529.
22. Belichenko I, Morishima N, Separovic DS: Caspase-resistant vimentin suppresses apoptosis after photodynamic treatment with a silicon phthalocyanine in Jurkat cells. Arch Biochem Biophys 2001;390:57-63.
23. Ohta K, Yachie A, Fujimoto K, Kaneda H, Wada T, Toma T, Seno A, Kasahara Y, Yokoyama H, Seki H, Koizumi S: Tubular injury as a cardinal pathologic feature in human oxygenase-1 deficiency. Am J Kidney Dis 2000;35:863-870.
24. Shiraishi F, Curtis LM, Poss K, Visner GA, Madsen K, Nick HS, Agarwal A: Heme oxygenase-1 gene ablation on expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol 2000;278:F726-F736.
25. Yang Y, Ohta K, Shimizu M, Morimoto K, Goto C, Nakai A, Toma T, Kasahara Y, Yachie A, Seki H, Koizumi S: Selective protection of renal tubular epithelial cells by heme oxygenase (HO)-1 during stress-induced injury. Kidney Int 2003;64:1302-1309.
26. Schaaf GJ, Maas RF, de Groene EM, Fink-Gremmels J: Management of oxidative stress by heme oxygenase-1 in cisplatin-induced toxicity in renal tubular cells. Free Radic Res 2002;36:835-843.
27. Huang Q, Dunn R, Jayadev S, DiSorbo O, Pack FD, Farr SB, Stoll RE, Blanchard KT: Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol Sci 2001;63:196-207.
28. Townsend DM, Deng M, Zhang L, Lapus MG, Hanigan MH: Metabolism of cisplatin to a nephrotoxin in proximal tubule cells. J Am Soc Nephrol 2003;14:1-10.
29. Ramesh G, Reeves WB: TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002;110:835-842.
30. Reddi AS, Bollineni JS: Selenium-deficient diet induces renal oxidative stress and injury via TGF-β1 in normal and diabetic rats. Kidney Int 2001;59:1342-1353.
31. Muthukumar A, Selvam R: Renal injury mediated calcium oxalate nephrolithiasis: role of lipid peroxidation. Ren Fail 1997;19:401-408.
32. Khan SR, Hackett RL: Hyperoxaluria, enzymuria and nephrolithiasis; in Bianchi C, Boci V Carone FA, Rabkin R (eds). Kidney, Proteins and Drugs: An Update. Contr Nephrol. Basel, Karger, 1993, vol 101, pp 190-193.
33. Baldew GS, Mol JGL, de Kanter FJJ, Barr BV, de Goeij JJM, Vermeulen NPE: The mechanism of interaction between cisplatin and selenate. Biochem Pharmacol 1991;41:1429-1437.
34. Baldew GS, van den Hamer CJA, Los G, Vermeulen NPE, de Goeji JJM, MeVie JG: Selenium-induced protection against cis-diamminedichloroplatinum (II) in mice and rats. Cancer Res 1989;49:3020-3023.